ChinaBio Today -- Last week was an active one in the world of China life science. The Thanksgiving holiday in the US may have put a damper on the number of stories (it’s not clear why the slowdown happens, though it’s very apparent that it does). Nevertheless, the holiday was not enough to stop a number of very significant announcements. Most importantly there was news of additional R&D investments, a new private equity fund and a China life science company IPO filing.
